Posters - NCDEU: An Annual Meeting Sponsored by ASCP
Posters - NCDEU: An Annual Meeting Sponsored by ASCP
Posters - NCDEU: An Annual Meeting Sponsored by ASCP
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Thursday, May 31, 2012<br />
Panel Sessions<br />
10:30 am – 12:00 pm Biologics for Addictions Treatment: Vaccines and<br />
Enzymes<br />
Frank Lloyd Wright Salon A-B<br />
Chairs: Thomas Kosten, M.D., Baylor College of Medicine<br />
Dave McCann, Ph.D., National Institute on Drug Abuse<br />
10:30 am – 10:50 am Nicotine Vaccine Recent Developments<br />
Marco Pravetoni, Ph.D., University of Minnesota<br />
10:50 am – 11:10 am A Vaccine Strategy against Heroin<br />
Kim D. Janda, Ph.D., Scripps Research Institute<br />
11:10 am – 11:30 am Cocaine Vaccine: Genetic and Immunological<br />
Response Predictors<br />
Thomas Kosten, M.D., Baylor<br />
11:30 am – 11:50 am Rodent Studies of Cocaine Hydrolase Delivered <strong>by</strong><br />
Gene Transfer as a Potential Future Treatment for<br />
Reducing Relapse in Recovering Cocaine Users<br />
Stephen Brimijoin, Ph.D., Mayo Clinic<br />
11:50 am – 12:00 pm General Discussion<br />
Dave McCann, Ph.D., National Institute on Drug Abuse<br />
10:30 am – 12:00 pm *Novel Methods for Evaluating the Harm-Benefit<br />
Balance in Outcomes of Randomized Clinical<br />
Trials: Demonstration of a New Approach<br />
Frank Lloyd Wright Salon C-D<br />
Chairs: Ellen Frank, Ph.D., University of Pittsburgh School of Medicine<br />
Helena Kraemer, Ph.D., Stanford University<br />
10:30 am – 10:55 am Rationale for an Integrated Harm-Benefit Measure<br />
Helena Kraemer, Ph.D., Stanford University<br />
10:55 am – 11:20 am A Pilot Study of the Integrated Preference Score<br />
(IPS) to Assess Harm-Benefit Balance in a<br />
Depression RCT<br />
Ellen Frank, Ph.D., University of Pittsburgh School of<br />
Medicine<br />
*of special interest to clinicians<br />
57
Change language